1. f-Phenylpropionylthiocholine and N-(5-aminopentyl)-5-dimethylaminonaphthalene-1-sulphonamide (dansylcadaverine) serve as a pair of water-soluble (pH7.5) model substrates for transamidating enzymes. Amide formation could be followed directly through fluorescence measurements by monitoring the continuous extraction ofthe water-insoluble coupling product, N-(fi-phenylpropionyl)dansylcadaverine, into n-heptane. By this procedure, the steady-state kinetics of glutamine-lysine endo-y-glutamyltransferase from human plasma (fibrinoligase, thrombin-and Ca2+-activated blood coagulation Factor XIII) and from guinea-pig liver (liver transglutaminase) were investigated at 25°C. 2. With f8-phenylpropionylthiocholine as the varied substrate, Lineweaver-Burk plots with various concentrations of dansylcadaverine intercept on the horizontal axis, suggesting that formation of the acyl-enzyme is rate limiting. 3. On the basis of functional normality of active sites, kcat. values of 1.8s-1 and 0.9s-1 were obtained for the plasma and liver y-glutamyltransferase respectively. The two enzymes show identical affinities for the first substrate, /,-phenylpropionylthiocholine, with Ka 4x 10-4M. 4. Utilization of the second substrate, dansylcadaverine, appears to be an order of magnitude more efficient with the liver enzyme. 5. N-(5-Amino-3-thiapentyl)-5-dimethylaminonaphthalene-1-sulphonamide (dansylthiacadaverine) could be used instead ofdansylcadaverine in the fluorescent kinetic system. 6. Competitive inhibition by a non-fluorescent amine substrate histamine was also evaluated.The enzymes used in this study may be regarded as Ca2+-dependent acyltransferases which catalyse the formation of y-glutaminyl-s-lysyl bridges between a glutaminyl acceptor and a donor lysine and also the incorporation of amines into proteins (e.g. putrescine into casein). In plasma, the active enzyme (fibrinoligase, FSF* or factor XIII,) is generated at the time of blood clotting from a zymogen precursor (fibrinstabilizing factor, FSF or factor XIII) for the purpose of catalysing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network (see Lorand, 1972). However, the functions of the other two related enzymes used in this investigation, namely, thrombin-activated platelet factor